All opinions my own and do not necessarily reflect those of Novo Nordisk.
A fair amount of reporting (for example here, here and here) has gone into the recent news that the NIH and the descendants of Henrietta Lacks have reached an agreement about the conditions under which the genome sequence of the HeLa cell line will be shared. The basic parameters are that researchers wanting access to the data will need to apply for permission, the application committee will include members of the Lacks family, any publications will acknowledge the contribution of the Henrietta Lacks, and future genome sequences will be submitted to dbGAP.
This is a generally welcome development, and in no small part due to the work of Rebecca Skloot. Her book, The Immortal Life of Henrietta Lacks provided the impetus to the current developments by popularizing the story of Ms. Lacks and the cell line derived from her tissues. However, this agreement also can be seen as a precedent of sorts, and the future implications for the ethics of consent, genetic information sharing and genomic research are unclear.
Whose genome is it, anyway?
In Pasco Phronesis, David Bruggeman penned a post on some of the possible implications. He discusses one of the key elements of genetic consent that I generally haven’t seen elaborated on much in the current literature: familial consent and exposure. To what extent do those who share part of a sequenced genome have a say in the granting and rescinding of consent for the usage of genetic information? Continue reading